US20678X1063 - Common Stock
Pre-market stock analysis on 2024-10-03: top gainers and losers in today's session.
Which stocks are moving after the closing bell on Wednesday?
SAN DIEGO and LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announced it will...
Conduit Pharmaceuticals stock is up on Wednesday alongside heavy trading following an invest update on CDT shares.
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!
Conduit Pharmaceuticals just reported results for the second quarter of 2024.
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders...
Conduit Pharmaceuticals stock is up on Thursday with heavy trading of CDT shares after the company announce a new license agreement.
It's time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning!
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments...
Greenpro Capital stock is down on Tuesday after shares of GRNQ underwent a major rally Monday with the announcement of a strategic alliance.
Autonomix Medical stock is down on Tuesday but that's only due to AMIX shares coming off of a massive 130% rally on Monday.
Conduit Pharmaceuticals stock is up with heavy trading of CDT shares on Tuesday after the company secured a new patent in Australia.
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning!
Composition of matter patent approval underscores the Company’s solid-form technology to maximize future value and ability to strengthen and broaden its intellectual property portfolio
Composition of matter patent approval underscores the Company’s solid-form technology to maximize future value and ability to strengthen and broaden its...
Conduit Pharmaceuticals to Join Russell 3000® Index...
Conduit Pharmaceuticals just reported results for the first quarter of 2024.
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer...
SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference...